Casandra
Casandra Test Code LC81122Version 1 (DRAFT)
Performing Lab
MDMA Confirmation (Labcorp MedWatch®)
Clinical Use
Order TestUse
Drug analysis/clinical drug monitoring
Special Instructions
This assay is intended for pain management. It is not intended for workplace testing and does not comply with state regulatory workplace testing programs.
Limitations
Not provided.
Test Details
Methodology
Mass Spectrometry
Biomarkers
Methylenedioxyamphetamine (MDA)
AnalyteMDA • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
methylenedioxyethylamphetamine (MDEA)
AnalyteMDEA • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
methylenedioxymethamphetamine (MDMA)
AnalyteMDMA • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
LOINC Codes
Order Codes
- 73971-4
- 19565-1
- 20545-0
- 19568-5
- 18358-2
- 59844-1
- 45143-5
Result Codes
- 73971-4
- 19565-1
- 20545-0
- 19568-5
- 18358-2
- 59844-1
- 45143-5
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
20 mL
Minimum Volume
Not provided
Container
Plastic urine container
Storage Instructions
Maintain specimen at room temperature. If arrival at lab will extend beyond seven days, refrigerate.
Causes for Rejection
Quantity not sufficient for analysis; incorrect specimen
Related Tests
Other tests from different labs that may be relevant
MDMA/MDA Screen, with Confirmation, Urine
Quest Diagnostics
Drug Monitor, MDMA/MDA, w/Conf, Urine
Quest Diagnostics
Drug Monitoring, MDMA/MDA, Quantitative, Urine
Quest Diagnostics
MDMA/MDA, Quantitative, Urine
Quest Diagnostics
MDMA/MDA
Quest Diagnostics
Mephedrone, MDPV and Methylone, Urine
Mayo Clinic Lab
Drug Monitoring, Methadone Metabolite, with Confirmation, Urine
Quest Diagnostics